PF4 and rheumatoid arthritis: In addition, Nguyen and colleagues showed that low pre-albumin and S100A12 levels associated with high platelet factor 4 (PF4) levels in pre-treatment could be good predictors for responses to infliximab, etanercept and adalimumab in patients with RA [187].